Cholinergic antagonist patch

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Web – sheet or filament bases; compositions of bandages; or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514292, 514946, 514947, A61F 1302

Patent

active

059620129

ABSTRACT:
Scopolamine is a folksy cholinergic antagonist, and is used by parasympathetic nerves in autonomic nervous neurons as an anti-motion sickness drug or an anti-emesis drug. Since the human body most effectively absorbs this drug through the postauricular skin, the drug is administered by postauricular transdermal resorption patch. The penetrability of drug is increase by adding a dermal penetrative enhancer, because the penetration ability of patch-administered drugs is usually decreased by the penetrative blockade at dermal horny layers. The present invention discloses a penetration enhancer to increase dermal absorption and penetration of the cholinergic antagonist. The present invention finds that polyethylene and amide enhance penetration, about 2.2-2.8 fold. In accordance with the present invention, a penetration enhancer is added to the formulations of transdermal patch to increase the human body's absorption of scopolamine.

REFERENCES:
patent: 5006342 (1991-04-01), Cleary et al.
patent: 5811117 (1998-09-01), Hashimoto et al.
patent: 5834010 (1998-11-01), Quan et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cholinergic antagonist patch does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cholinergic antagonist patch, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cholinergic antagonist patch will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1168618

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.